Since 2019, DEC has invested in enhancing it’s capabilities in developing and manufacturing polymer composite-based delivery solutions, which has the advantage of more precise drug delivery control compared to traditional silicone-based delivery solutions.
DEC can unlock commercial opportunities for our partners through expertise in the handling of complex molecules at scale, superior and consistent manufacturing quality standard, technical expertise in developing effective drug delivery solutions and our speed to market.
